Multiple Sclerosis
Multiple Sclerosis
MS is an autoimmune demyelinating CNS disease. RRMS (most common): relapsing-remitting. Presents with optic neuritis, sensory/motor deficits, bladder dysfunction. DMTs reduce relapse rate.
Latest evidence
Intrapartum Care for Women with Multiple Sclerosis: A JBI-Guided Scoping Review and Evidence Synthesis of Clinical Practices and Maternal Outcomes.
Perspective of Disease and Treatment in Patients with Multiple Sclerosis: A Polish Multi-center Study.
Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients.
Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level.
What this condition is
What is multiple sclerosis?Multiple sclerosis (MS) is a disease that affects your brain and spinal cord, also called the central nervous system. MS damages myelin, the protective coating around your nerve cells. Myelin helps nerves send messages quickly. When it's damaged, messages between your brain and body slow down or get blocked. This leads to MS symptoms.What are the types of multiple sclerosis?Not everyone wi…
Open official source →Terms and documentation support
Condition matches & synonyms
TermsRelated diagnostic names, synonyms, and documentation wording that may appear in clinical references and charting.
ICD-10 quick links
CodesFor study support, terminology recognition, and documentation language.
Tests performed
Recognize the drug and the class
NANDA diagnoses & care plans
Use these direct links to open nursing diagnoses and care-plan support related to Multiple Sclerosis.
Additional official research
A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis
The goal of this clinical trial is to evaluate the safety and tolerability of terfenadine when added to standard first-line disease-modifying therapy in adults with multiple sclerosis. The study will also explore whether adding terfenadine…
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
Academic research project monitoring the effect of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) on multiple sclerosis-associated lower urinary tract symptoms.
Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are: * Does the presence of ACE impact on quality of life of…
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) to the treatment strategy of Best Ava…
Ocrevus Zunovo for MS: Mixed Methods
Ocrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods study. This study will incorporate clinical data and questionn…
Plain-language study support
Useful for plain-language reinforcement and quick review.